A case of sclerosing panniculitis treated with stanozolol

Jun Ha Park, Kyu Chul Hwang, Jae Hong Park, Soo Nam Kim, Young Chul Kye

    Research output: Contribution to journalArticlepeer-review

    1 Citation (Scopus)


    Sclerosing panniculitis refers to indurated erythema with hyperpigmented scleroderma-like hardening on the medial lower third of the legs. It has been called indurated cellulitis, chronic cellulitis, hypodermitis sclerodermiformis or lipodermatosclerosis. It has been suggested that sclerosing panniculitis is associated with venous insufficiency. The treatment of sclerosing panniculitis is very difficult. Stanozolol is valuable in treating intractable sclerosing panniculitis, giving relief of pain, reducing induration, inflammation, tenderness and pigmentation by its fibrinolytic activity. We report a case of sclerosing panniculitis, clinically improved by stanozolol.

    Original languageEnglish
    Pages (from-to)893-896
    Number of pages4
    JournalKorean Journal of Dermatology
    Issue number7
    Publication statusPublished - 2004 Jul


    • Indurated cellulitis
    • Lipodermatosclerosis
    • Sclerosing panniculitis
    • Stanozolol

    ASJC Scopus subject areas

    • Dermatology


    Dive into the research topics of 'A case of sclerosing panniculitis treated with stanozolol'. Together they form a unique fingerprint.

    Cite this